Blocking microsomal triglyceride transfer protein interferes with apoB secretion without causing retention or stress in the ER

Journal of Lipid Research

Volumn 44, Issue 5, 2003, Pages 978-985

  Liao, Wei ^a   Hui, To Y ^a   Young, Stephen G ^b   Davis, Roger A ^a  

^a SAN DIEGO STATE UNIVERSITY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Apolipoprotein B; Endoplasmic reticulum; Hyperlipidemia; Inflammation; Liver; Unfolded protein response

Indexed keywords

APOLIPOPROTEIN B; CHAPERONE; CHOLESTEROL; GLUCOSE REGULATED PROTEIN; GLUCOSE REGULATED PROTEIN 78; GLUCOSE REGULATED PROTEIN 94; HEAT SHOCK PROTEIN 60; HEAT SHOCK PROTEIN 70; HEAT SHOCK PROTEIN 90; ISOPROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR; MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN; PROTEIN DISULFIDE ISOMERASE; PROTEIN INHIBITOR; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; ENDOPLASMIC RETICULUM; GENE; LIVER MICROSOME; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN SECRETION; STRESS; TRIACYLGLYCEROL BLOOD LEVEL; WILD TYPE;

ANIMALS; APOLIPOPROTEINS B; BENZAMIDES; CARRIER PROTEINS; ENDOPLASMIC RETICULUM; FEMALE; INDENES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICROSOMES, LIVER; RECEPTORS, LDL; TRIGLYCERIDES;

EID: 0142042348     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: 10.1194/jlr.M300020-JLR200     Document Type: Article

References (56)

1. MRC/BHF Heart Protection Study Group. 2002. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet. 360: 7-22.
2. Kayden, H. J. 1972. Abetalipoproteinemia. Annu. Rev. Med. 23: 285-296.
3. Kayden, H. J., and M. G. Traber. 1986. Clinical, nutritional and biochemical consequences of apolipoprotein B deficiency. Adv. Exp. Med. Biol. 201: 67-81.
4. Wetterau, J. R., L. P. Aggerbeck, M.-E. Bouma, C. Eisenberg, A. Munck, M. Hermier, J. Schmitz, G. Gay, D. Rader, and R. E. Gregg. 1992. Absence of microsomal triglyceride transfer protein in individuals with abetalipoproteinemia. Science. 258: 999-1001.
5. Gregg, R. E., and J. R. Wetterau. 1994. The molecular basis of abetalipoproteineimia. Curr. Opin. Lipidol. 5: 81-86.
6. Wetterau, J. R., and D. B. Zilversmit. 1985. Purification and characterization of microsomal triglyceride and cholesteryl ester transfer protein from bovine liver microsomes. Chem. Phys. Lipids. 38: 205-222.
7. Wetterau, J. R., K. A. Combs, S. N. Spinner, and B. J. Joiner. 1990. Protein disulfide isomerase is a component of the microsomal triglyceride transfer protein complex. J. Biol. Chem. 265: 9801-9807.
8. Iannaccone, S. T., and R. J. Sokol. 1986. Vitamin E deficiency in neuropathy of abetalipoproteinemia. Neurology. 36: 1009.
9. Jamil, H., D. A. Gordon, D. C. Eustice, C. M. Brooks, J. J. Dickson, Y. Chen, B. Ricci, C. H. Chu, T. W. Harrity, C. J. Ciosek, S. A. Biller, R. E. Gregg, and J. R. Wetterau. 1996. An inhibitor of the microsomal triglyceride transfer protein inhibits apoB secretion from HepG2 cells. Proc. Natl. Acad. Sci. USA. 93: 11991-11995.
10. Bakillah, A., N. Nayak, U. Saxena, R. M. Medford, and M. M. Hussain. 2000. Decreased secretion of ApoB follows inhibition of ApoB-MTP binding by a novel antagonist. Biochemistry. 39: 4892-4899.
11. Ksander, G. M., R. deJesus, A. Yuan, C. Fink, M. Moskal, E. Carlson, P. Kukkola, N. Bilci, E. Wallace, A. Neubert, D. Feldman, T. Mogelesky, K. Poirier, M. Jeune, R. Steele, J. Wasvery, Z. Stephan, E. Cahill, R. Webb, A. Navarrete, W. Lee, J. Gibson, N. Alexander, H. Sharif, and A. Hospattankar. 2001. Diaminoindanes as microsomal triglyceride transfer protein inhibitors. J. Med. Chem. 44: 4677-4687.
12. Chang, G., R. B. Ruggeri, and H. J. Harwood, Jr. 2002. Microsomal triglyceride transfer protein (MTP) inhibitors: discovery of clinically active inhibitors using high-throughput screening and parallel synthesis paradigms. Curr. Opin. Drug Discov. Devel. 5: 562-570.
13. Wetterau, J. R., R. E. Gregg, T. W. Harrity, C. Arbeeny, M. Cap, F. Connolly, C. H. Chu, R. J. George, D. A. Gordon, H. Jamil, K. G. Jolibois, L. K. Kunselman, S. J. Lan, T. J. Maccagnan, B. Ricci, M. Yan, D. Young, Y. Chen, O. M. Fryszman, J. V. Logan, C. L. Musial, M. A. Poss, J. A. Robl, L. M. Simpkins, W. A. Slusarchyk, R. Sulsky, P. Taunk, D. R. Magnin, J. A. Tino, R. M. Lawrence, J. Dickson, and S. A. Biller. 1998. An MTP inhibitor that normalizes atherogenic lipoprotein levels in WHHL rabbits. Science. 282: 751-754.
14. Uauy, R., G. L. Vega, S. M. Grundy, and D. M. Bilheimer. 1988. Lovastatin therapy in receptor-negative homozygous familial hypercholesterolemia: lack of effect on low-density lipoprotein concentrations or turnover. J. Pediatr. 113: 387-392.
15. Bilheimer, D. W., J. L. Goldstein, S. M. Grundy, T. E. Starzl, and M. S. Brown. 1984. Liver transplantation to provide low-density-lipoprotein receptors and lower plasma cholesterol in a child with homozygous familial hypercholesterolemia. N. Engl. J. Med. 311: 1658-1664.
16. Yao, Z., K. Tran, and R. S. McLeod. 1997. Intracellular degradation of newly synthesized apolipoprotein B. J. Lipid Res. 38: 1937-1953.
17. Davis, R. A. 1999. Cell and molecular biology of the assembly and secretion of apolipoprotein B-containing lipoproteins by the liver. Biochim. Biophys. Acta. 1440: 1-31.
18. Olofsson, S. O., L. Asp, and J. Boren. 1999. The assembly and secretion of apolipoprotein B-containing lipoproteins. Curr. Opin. Lipidol. 10: 341-346.
19. Davidson, N. O., and G. S. Shelness. 2000. Apolipoprotein B: mRNA editing, lipoprotein assembly, and presecretory degradation. Annu. Rev. Nutr. 20: 169-193.
20. Fisher, E. A., and H. N. Ginsberg. 2002. Complexity in the secretory pathway: the assembly and secretion of apolipoprotein B-containing lipoproteins. J. Biol. Chem. 277: 17377-17380.
21. Du, E., J. Kurth, S-L. Wang, P. Humiston, and R. A. Davis. 1994. Proteolysis-coupled secretion of the N-terminus of apolipoprotein B: characterization of a transient, translocation arrested intermediate. J. Biol. Chem. 269: 24169-24176.
22. Raabe, M., M. M. Veniant, M. A. Sullivan, C. H. Zlot, J. Bjorkegren, L. B. Nielsen, J. S. Wong, R. L. Hamilton, and S. G. Young. 1999. Analysis of the role of microsomal triglyceride transfer protein in the liver of tissue-specific knockout mice. J. Clin. Invest. 103: 1287-1298.
23. Chang, B. H., W. Liao, L. Li, M. Nakamuta, D. Mack, and L. Chan. 1999. Liver-specific inactivation of the abetalipoproteinemia gene completely abrogates very low density lipoprotein/low density lipoprotein production in a viable conditional knockout mouse. J. Biol. Chem. 274: 6051-6055.
24. Du, E. Z., S-L. Wang, H. J. Kayden, R. Sokol, L. K. Curtiss, and R. A. Davis. 1996. Translocation of apolipoprotein B across the endoplasmic reticulum is blocked in abetalipoproteinemia. J. Lipid Res. 37: 1309-1315.
25. Benoist, F., and P. T. Grand. 1997. Co-translational degradation of apolipoprotein B100 by the proteasome is prevented by microsomal triglyceride transfer protein. Synchronized translation studies on HepG2 cells treated with an inhibitor of microsomal triglyceride transfer protein. J. Biol. Chem. 272: 20435-20442.
26. Wang, L., D. G. Fast, and A. D. Attie. 1997. The enzymatic and non-enzymatic roles of protein-disulfide isomerase in apolipoprotein B secretion. J. Biol. Chem. 272: 27644-27651.
27. Hussain, M. M., A. Bakillah, and H. Jamil. 1997. Apolipoprotein B binding to microsomal triglyceride transfer protein decreases with increases in length and lipidation: implications in lipoprotein biosynthesis. Biochemistry. 36: 13060-13067.
28. Liang, J. S., X. Wu, H. Jiang, M. Zhou, H. Yang, P. Angkeow, L. S. Huang, S. L. Sturley, and H. Ginsberg. 1998. Translocation efficiency, susceptibility to proteasomal degradation, and lipid responsiveness of apolipoprotein B are determined by the presence of beta sheet domains. J. Biol. Chem. 273: 35216-35221.
29. Rustaeus, S., P. Stillemark, K. Lindberg, D. Gordon, and S. O. Olofsson. A998. The microsomal triglyceride transfer protein catalyzes the post-translational assembly of apolipoprotein B-100 very low density lipoprotein in McA-RH7777 cells. J. Biol. Chem. 273: 5196-5203.
30. Mitchell, D. M., M. Zhou, R. Pariyarath, H. Wang, J. D. Aitchison, H. N. Ginsberg, and E. A. Fisher. 1998. Apoprotein B100 has a prolonged interaction with the translocon during which its lipidation and translocation change from dependence on the microsomal triglyceride transfer protein to independence. Proc. Natl. Acad. Sci. USA. 95: 14733-14738.
31. Nicodeme, E., F. Benoist, R. McLeod, Z. Yao, J. Scott, C. C. Shoulders, and P. T. Grand. 1999. Identification of domains in apolipoprotein B100 that confer a high requirement for the microsomal triglyceride transfer-protein. J. Biol. Chem. 274: 1986-1993.
32. Kulinski, A., S. Rustaeus, and J. E. Vance. 2002. Microsomal triacylglycerol transfer protein is required for lumenal accretion of triacylglycerol not associated with ApoB, as well as for ApoB lipidation. J. Biol. Chem. 277: 31516-31525.
33. Davis, R. A., R. N. Thrift, C. C. Wu, and K. E. Howell. 1990. Apolipoprotein B is both integrated into and translocated across the endoplasmic reticulum membrane. Evidence for two functionally distinct pools. J. Biol. Chem. 265: 10005-10011.
34. Yeung, S. J., S. H. Chen, and L. Chan. 1996. Ubiquitin-proteasome pathway mediates intracellular degradation of apolipoprotein B. Biochemistry. 35: 13843-13848.
35. Fisher, E. A., M. Zhou, D. M. Mitchell, X. Wu, S. Omura, H. Wang, A. L. Goldberg, and H. N. Ginsberg. 1997. The degradation of apolipoprotein B100 is mediated by the ubiquitin-proteasome pathway and involves heat shock protein 70. J. Biol. Chem. 272: 20427-20434.
36. Liang, J., X. Wu, E. A. Fisher, and H. N. Ginsberg. 2000. The amino-terminal domain of apolipoprotein B does not undergo retrograde translocation from the endoplasmic reticulum to the cytosol. Proteasomal degradation of nascent apolipoprotein b begins at the carboxyl terminus of the protein, while apolipoprotein b is still in its original translocon. J. Biol. Chem. 275: 32003-32010.
37. Bonnardel, J. A., and R. A. Davis. 1995. In HepG2 cells, translocation, not degradation, determines the fate of de novo synthesized apolipoprotein B. J. Biol. Chem. 270: 28892-28896.
38. Hampton, R. Y. 2000. ER stress response: getting the UPR hand on misfolded proteins. Curr. Biol. 10: R518-R521.
39. Urano, F., A. Bertolotti, and D. Ron. 2000. IRE1 and efferent signaling from the endoplasmic reticulum. J. Cell Sci. 113: 3697-3702.
40. Patil, C., and P. Walter. 2001. Intracellular signaling from the endoplasmic reticulum to the nucleus: the unfolded protein response in yeast and mammals. Curr. Opin. Cell Biol. 13: 349-355.
41. Miyake, J. H., X. D-T. Duong, J. M. Taylor, E. Z. Du, L. W. Castellani, A. J. Lusis, and R. A. Davis. 2002. Transgenic expression of cholesterol-7a-hydroxylase prevents atherosclerosis in C57BL/6J mice. Arterioscler. Thromb. Vasc. Biol. 22: 121-126.
42. Wetterau, J. R., M. C. Lin, and H. Jamil. 1997. Microsomal triglyceride transfer protein. Biochim. Biophys. Acta. 1345: 136-150.
43. Thrift, R. N., J. Drisko, S. Dueland, J. D. Trawick, and R. A. Davis. 1992. Translocation of apolipoprotein B across the endoplasmic reticulum is blocked in a nonhepatic cell line. Proc. Natl. Acad. Sci. USA. 89: 9161-9165.
44. Du, E. Z., J. F. Fleming, S-L. Wang, G. M. Spitzen, and R. A. Davis. 1999. Translocation-arrested apolipoprotein B evades proteasome degradation via a sterol-sensitive block in ubiquitin conjugation. J. Biol. Chem. 274: 1856-1862.
45. Wang, S., R. S. McLeod, D. A. Gordon, and Z. Yao. 1996. The microsomal triglyceride transfer protein facilitates assembly and secretion of apolipoprotein B-containing lipoproteins and decreases cotranslational degradation of apolipoprotein B in transfected COS-7 cells. J. Biol. Chem. 271: 12124-12133.
46. Liao, W., S. Yeung, and L. Chan. 1998. Proteasome-mediated degradation of apolipoprotein B targets both nascent peptides cotranslationally before translocation and full-length apolipoprotein B after translocation into the endoplasmic reticulum. J. Biol. Chem. 273: 27225-27230.
47. Pariyarath, R., H. Wang, J. D. Aitchison, H. N. Ginsberg, W. J. Welch, A. E. Johnson, and E. A. Fisher. 2001. Co-translational interactions of apoprotein B with the ribosome and translocon during lipoprotein assembly or targeting to the proteasome. J. Biol. Chem. 276: 541-550.
48. Bjorkegren, J., A. Beigneux, M. O. Bergo, J. J. Maher, and S. G. Young. 2002. Blocking the secretion of hepatic very low density lipoproteins renders the liver more susceptible to toxin-induced injury. J. Biol. Chem. 277: 5476-5483.
49. Twisk, J., D. L. Gillian-Daniel, A. Tebon, L. Wang, P. H. Barrett, and A. D. Attie. 2000. The role of the LDL receptor in apolipoprotein B secretion. J. Clin. Invest. 105: 521-532.
50. Gillian-Daniel, D. L., P. W. Bates, A. Tebon, and A. D. Attie. 2002. Endoplasmic reticulum localization of the low density lipoprotein receptor mediates presecretory degradation of apolipoprotein B. Proc. Natl. Acad. Sci. USA. 99: 4337-4342.
51. Brown, M. S., R. G. Anderson, and J. L. Goldstein. 1983. Recycling receptors: the round-trip itinerary of migrant membrane proteins. Cell. 32: 663-667.
52. Knott, T. J., R. J. Pease, L. M. Powell, S. C. Wallis, S. C. Rall, T. L. Innerarity, B. Blackhart, W. H. Taylor, Y. Marcel, R. Milne, D. Johnson, M. Fuller, A. J. Lusis, B. J. McCarthy, R. W. Mahley, B. Levy-Wilson, and J. Scott. 1986. Complete protein sequence and identification of structural domains of human apolipoprotein B. Nature. 323: 734-738.
53. Yang, C-Y., S-H. Chen, S. H. Gianturco, W. A. Bradley, J. T. Sparrow, M. Tanimura, W-H. Li, D. A. Sparrow, H. DeLoof, M. Rosseneu, F. Lee, Z-W. Gu, A. M. Gotto, and L. Chan. 1986. Sequence, structure, receptor-binding domains and internal repeats of human apolipoprotein B-100. Nature. 323: 738-742.
54. Collins, J. C., I. H. Scheinberg, D. R. Giblin, and I. Sternlieb. 1989. Hepatic peroxisomal abnormalities in abetalipoproteinemia. Gastroenterology. 97: 766-770.
55. Ohashi, K., S. Ishibashi, J. Osuga, R. Tozawa, K. Harada, N. Yahagi, F. Shionoiri, Y. Iizuka, Y. Tamura, R. Nagai, D. R. Illingworth, T. Gotoda, and N. Yamada. 2000. Novel mutations in the microsomal triglyceride transfer protein gene causing abetalipoproteinemia. J. Lipid Res. 41: 1199-1204.
56. Saito, K. S. Matsumoto, T. Yokoyama, M. Okaniwa, and S. Kamoshita. 1982. Pathology of chronic vitamin E deficiency in fatal familial intrahepatic cholestasis (Byler disease). Virchows Arch. 396: 319-330.